Taniguchi, H., Takeuchi, S., Fukuda, K., Nakagawa, T., Arai, S., Nanjo, S., . . . Yano, S. (2016). Amphiregulin triggered epidermal growth factor receptor activation confers in vivo crizotinib‐resistance of EML4‐ALK lung cancer and circumvention by epidermal growth factor receptor inhibitors. Cancer Sci.
シカゴスタイル引用形Taniguchi, Hirokazu, et al. "Amphiregulin Triggered Epidermal Growth Factor Receptor Activation Confers in Vivo Crizotinib‐resistance of EML4‐ALK Lung Cancer and Circumvention By Epidermal Growth Factor Receptor Inhibitors." Cancer Sci 2016.
MLA引用形式Taniguchi, Hirokazu, et al. "Amphiregulin Triggered Epidermal Growth Factor Receptor Activation Confers in Vivo Crizotinib‐resistance of EML4‐ALK Lung Cancer and Circumvention By Epidermal Growth Factor Receptor Inhibitors." Cancer Sci 2016.